Estrogen regulation of the cytochrome P450 3A subfamily in humans

被引:44
作者
Williams, ET
Leyk, M
Wrighton, SA
Davies, PJA
Loose, DS
Shipley, GL
Strobel, HW
机构
[1] Univ Texas, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA
[2] Univ Texas, Hlth Sci Ctr, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX USA
[3] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA
[4] Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA
关键词
D O I
10.1124/jpet.104.068908
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study examines the possible role of estrogen in regulating the expression of the human CYP3A subfamily: CYP3A4, CYP3A5, CYP3A7, and CYP3A43. To accomplish this goal, mRNA was quantified from human livers and endometrial samples, and total CYP3A protein levels were evaluated by Western immunoblot analysis of the liver samples. The human endometrial samples were from premenopausal and postmenopausal women. The premenopausal endometrium was either in the proliferative or secretory phase, whereas for the postmenopausal endometrium samples, the women had been treated with either a placebo or estropipate, an estrogen substitute. After analyses, CYP3A4 mRNA was shown to have lower hepatic expression in females than in males. In the endometrium, CYP3A4 and CYP3A43 are down-regulated by estrogen, whereas CYP3A5 is expressed at higher levels during the secretory phase. CYP3A7 was not detected in the endometrium. In addition, the CYP3A subfamily showed increased mRNA expression in the liver as age increased. The expression levels of total CYP3A protein and total CYP3A mRNA showed good correlation. Despite apparent regulation of CYP3A4 mRNA expression by estrogen, the effects of estrogen may be overshadowed by additional regulators of gene expression.
引用
收藏
页码:728 / 735
页数:8
相关论文
共 26 条
  • [1] Insights into gender bias: Rat cytochrome P450 3A9
    Anakk, S
    Ku, CY
    Vore, M
    Strobel, HW
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02) : 703 - 709
  • [2] CATALYTIC ACTIVITIES OF HUMAN LIVER CYTOCHROME-P-450-IIIA4 EXPRESSED IN SACCHAROMYCES-CEREVISIAE
    BRIAN, WR
    SARI, MA
    IWASAKI, M
    SHIMADA, T
    KAMINSKY, LS
    GUENGERICH, FP
    [J]. BIOCHEMISTRY, 1990, 29 (51) : 11280 - 11292
  • [3] Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine
    Burk, O
    Tegude, H
    Koch, I
    Hustert, E
    Wolbold, R
    Glaeser, H
    Klein, K
    Fromm, MF
    Nuessler, AK
    Neuhaus, P
    Zanger, UM
    Eichelbaum, M
    Wojnowski, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 24280 - 24288
  • [4] Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium
    Deng, L
    Shipley, GL
    Loose-Mitchell, DS
    Stancel, GM
    Broaddus, R
    Pickar, JH
    Davies, PJA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) : 2157 - 2163
  • [5] cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome p450
    Domanski, TL
    Finta, C
    Halpert, JR
    Zaphiropoulos, PG
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (02) : 386 - 392
  • [6] Pharmacogenomics: Translating functional genomics into rational therapeutics
    Evans, WE
    Relling, MV
    [J]. SCIENCE, 1999, 286 (5439) : 487 - 491
  • [7] Genomic organization of the human CYP3A locus:: identification of a new, inducible CYP3A gene
    Gellner, K
    Eiselt, R
    Hustert, E
    Arnold, H
    Koch, I
    Haberl, M
    Deglmann, CJ
    Burk, O
    Buntefuss, D
    Escher, S
    Bishop, C
    Koebe, HG
    Brinkmann, U
    Klenk, HP
    Kleine, K
    Meyer, UA
    Wojnowski, L
    [J]. PHARMACOGENETICS, 2001, 11 (02): : 111 - 121
  • [8] The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
    Goodwin, B
    Hodgson, E
    Liddle, C
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1329 - 1339
  • [9] The effect of hormone replacement therapy on CYP3A activity
    Gorski, JC
    Wang, ZQ
    Heahner-Daniels, BD
    Wrighton, SA
    Hall, SD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (04) : 412 - 417
  • [10] Guengerich FP, 1995, CYTOCHROME P, P473